Updated April 13, 2025
The Food and Drug Administration (FDA) plays a pivotal role in shaping and enforcing guidelines that ensure the safety and effectiveness of medical devices. Central to this role are four critical security architecture views: Global System View, Multi-Patient Harm View, Updateability/Patchability View, and Security Use Case View(s). Each perspective offers a unique lens through which the FDA assesses and manages the cybersecurity risks associated with medical devices.
Global System View
The concept of a Global System View in medical device cybersecurity recognizes that devices operate not in isolation but as part of a broader system of interconnected components, which includes networks and other medical and non-medical devices. This holistic perspective is crucial for manufacturers to ensure that the devices they develop are secure in themselves and within their environments.
Example: Consider a wireless insulin pump that communicates with other devices and systems, such as glucose monitoring systems, mobile health applications, and patient data management systems. This device’s effectiveness and safety depend on its security features and how well it integrates and interacts with other systems. If the glucose monitor transmits data over a network that isn’t secure, it could be intercepted or tampered with, leading to incorrect insulin dosing by the pump.
Hence, the FDA encourages manufacturers to consider external factors like network security protocols, the types of data exchanges, and the compatibility with other systems and devices. For instance, ensuring that the insulin pump and glucose monitor are mutually compatible and secure communication protocols can prevent unauthorized access and ensure data integrity. Understanding the potential risk scenarios, such as a breach in the network that could lead to a denial of service, helps develop more resilient systems. Manufacturers are advised to conduct comprehensive risk assessments that consider these interconnected elements and implement security measures that address identified risks comprehensively, thus ensuring the device’s functionality and safety in a connected healthcare environment.
Multi-Patient Harm View
The Multi-Patient Harm View emphasizes the importance of understanding and mitigating risks beyond individual patient interactions with a medical device, particularly in contexts where devices are interconnected or rely on shared platforms. This perspective compels manufacturers to address vulnerabilities that could lead to simultaneous adverse effects on multiple patients, enhancing the healthcare ecosystem’s overall safety and security protocols.
Example: Imagine a cloud-based health monitoring system used by a hospital to remotely track the vital signs of patients using connected wearable devices. If this system’s software is compromised due to an undetected vulnerability, the breach could potentially alter the vital sign data of not just one but numerous patients. Such alterations could lead to incorrect clinical assessments, misdiagnoses, and inappropriate medical interventions across a wide patient base.
In response to such risks, the FDA advises manufacturers to implement layered security measures and conduct thorough risk assessments that account for network and software vulnerabilities. For example, end-to-end encryption for transmitting patient data can prevent unauthorized access and tampering. Additionally, implementing regular security updates and patches for the software platform can address vulnerabilities as they are discovered.
Manufacturers should also consider deploying anomaly detection systems that monitor for unusual activities that could indicate a cybersecurity event. For example, if the data patterns suddenly change in an improbable way across multiple devices, the health monitoring system could flag these changes for immediate review.
Comprehensive risk management plans considering the potential for widespread impact should support deploying these strategies. This might include simulations of security breaches to test the system’s response procedures and develop incident response plans to quickly isolate affected devices and systems, minimizing potential patient harm. Through such proactive measures, manufacturers can better protect patients from the cascading effects of cybersecurity threats in increasingly interconnected medical environments.
Updateability/Patchability View
The FDA’s Updateability/Patchability View reflects the understanding that cybersecurity threats constantly evolve, necessitating a medical device’s ability to receive and implement software updates and patches efficiently and securely. This ongoing capability to adapt is essential for maintaining the device’s defense against new vulnerabilities as they arise.
Example: Consider a network of connected pacemakers that can be monitored and adjusted remotely via a healthcare provider’s computer system. If a vulnerability is discovered in the pacemaker’s software that could allow hackers to manipulate the device’s function remotely, the potential impact on patient safety is significant. The ability to quickly and securely update the software on these pacemakers is crucial to mitigate any risks posed by the vulnerability.
The FDA encourages manufacturers to design devices with built-in mechanisms for secure and reliable software updates to support this need. This might include features such as encrypted firmware updates that can be authenticated before installation to prevent unauthorized modifications. These updates should be designed to occur with minimal or no disruption to the device’s normal operation, ensuring that the pacemaker continues to perform its critical functions without interruption during the update process.
Additionally, manufacturers should consider implementing automatic update features that allow devices to receive and install patches as soon as they become available without requiring manual intervention by the healthcare provider or the patient. This approach ensures that security updates are implemented as quickly as possible, reducing the window of vulnerability.
Manufacturers are also advised to establish a regular schedule for checking and updating their devices’ security features, aligning with best practices for software maintenance. This includes continuously monitoring for threats and vulnerabilities and engaging in proactive community and industry collaboration to stay informed about cybersecurity trends and countermeasures.
By adopting these strategies, manufacturers comply with FDA guidelines and significantly enhance the resilience of medical devices against the evolving landscape of cybersecurity threats, thereby safeguarding patient health and trust in medical technologies.
Security Use Case View(s)
The Security Use Case View(s) is a strategic approach encouraged by the FDA that requires manufacturers to thoroughly analyze and plan for various scenarios where a medical device might be susceptible to cybersecurity threats. By anticipating different security challenges, manufacturers can design robust and resilient devices against potential breaches and misuse, ensuring device functionality and patient safety.
Example: Consider a hospital-grade infusion pump that administers medication at programmable rates. A potential use case for security analysis might involve the device’s wireless communication capabilities, which could be exploited to alter the dosage settings. This scenario could lead to overdoses or insufficient dosing, posing serious risks to patients.
To address such risks, manufacturers are urged to conduct a detailed examination of possible attack vectors, such as:
- Unauthorized Access: Assessing how an unauthorized person could gain control of the device, perhaps through stolen credentials or via an unsecured network connection.
- Data Breaches: Evaluating the potential for sensitive data, such as patient health information, to be accessed or stolen through the device.
- Device Malfunction: Considering scenarios where a cyberattack could disrupt the normal operation of the device, leading to incorrect medication delivery.
The FDA recommends that manufacturers develop specific mitigation strategies for each scenario. For instance, incorporating strong authentication and access control measures can prevent unauthorized access. Data encryption can protect patient information, ensuring it remains unreadable and secure even if data is intercepted. Implementing robust error-checking and recovery procedures can enhance the device’s ability to maintain correct functionality even under attack.
Manufacturers should consider including real-time monitoring systems within the device’s firmware. These systems can detect and alert healthcare providers to unauthorized attempts to modify device settings or access sensitive data.
In addition to technical measures, the FDA advises ongoing training for end-users, such as hospital staff, on the potential cybersecurity risks and the steps they can take to mitigate them. This educational approach helps create a comprehensive security culture surrounding the use of medical devices.
Manufacturers meet FDA expectations and build trust with healthcare providers and patients by understanding and preparing for these use cases. They also ensure that their devices can resist real-world security challenges and continue to perform their critical functions effectively.
Conclusion
The FDA’s approach to medical device security, encapsulated in these four views, reflects a comprehensive and dynamic strategy. By considering the global system in which devices operate, the potential for multi-patient harm, the necessity of continuous updates, and various security use cases, the FDA aims to ensure that medical devices are effective in their medical purpose and robust in their security architecture. As technology evolves, these views will continue to guide manufacturers and regulators in safeguarding the intersection of healthcare and cybersecurity.
Check out our full-service premarket cybersecurity offer.
Medical Device Security Architecture View FAQs
- Global System View
- Multi-Patient Harm View
- Updateability and Patchability View
- Security Use Case Views
These views collectively demonstrate how cybersecurity is integrated into the medical device design and its operating environment.
The Global System View provides a high-level diagram of the medical device and its ecosystem, including all connected components such as cloud services, mobile apps, hospital networks, and other systems. It helps reviewers understand data flows, trust boundaries, and external dependencies.
This view addresses risks where a cybersecurity event could impact multiple patients at once—such as shared cloud platforms or remote management systems. It shows how your device architecture prevents or mitigates systemic, widespread harm.
This view shows how the medical device can receive security updates and patches after deployment. It includes mechanisms for secure update delivery, authentication, rollback prevention, and timelines for applying patches—key to lifecycle risk management.
Security Use Case Views present operational scenarios (e.g., authentication, remote connection, or data transfer) that illustrate how the device enforces security during normal and edge-case usage. These views demonstrate that security controls are functional, effective, and well-integrated in real-world conditions.
Each view should be detailed enough to clearly illustrate security controls, data flows, access points, and risk mitigation strategies. The FDA expects enough granularity to understand how vulnerabilities are prevented, detected, and managed across the system.
Yes. The Global System View must include all software modules, cloud services, APIs, and third-party platforms the device interacts with. This ensures the FDA can evaluate external risk exposure and trust boundaries.
You can use standard modeling tools such as Microsoft Visio, Lucidchart, or UML-based design tools. The key is clarity—diagrams should be easy to interpret and supported by explanatory text to meet FDA expectations.
Yes. While primarily part of premarket submissions, this view also supports FDA postmarket expectations by showing how your device maintains cybersecurity throughout its lifecycle via secure updates and patching procedures.
These views demonstrate that cybersecurity has been integrated across the device ecosystem—not just the embedded software. They show the FDA how your device prevents unauthorized access, protects data integrity, and minimizes risk across interconnected components.
